Endocyte
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Endocyte's past years’ income statements indicate that its last revenue has compared to the previous period by 0% to $70,000. Profit margin reached -100802%. Total operating expenses were $39,636,698.
Profit Margin
| 2013 | 64.87M | -18.03M | -27.8% |
|---|---|---|---|
| 2014 | 70.35M | 5.45M | 7.76% |
| 2015 | 70K | -40.56M | -57952.23% |
| 2016 | 70K | -43.05M | -61506.89% |
| 2017 | 70K | -70.56M | -100802.29% |
ECYT Income Statement (2013 – 2017)
| 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 70K | 70K | 70K | 70.35M | 64.87M |
Cost of revenue | 0 | 0 | 0 | 0 | 0 |
Gross profit | 70K | 70K | 70K | 70.35M | 64.87M |
Operating exp. | |||||
Research and development | 25.86M | 27.49M | 26.30M | 41.64M | 57.89M |
Selling and marketing | 0 | 139 | -538 | 366 | -269 |
Total operating expenses | 39.63M | 44.79M | 42.04M | 65.32M | 83.21M |
Operating income | -56.10M | -44.72M | -41.97M | 5.02M | -18.34M |
Other income (expenses), net | 1.04M | 832.75K | 703.18K | 432.74K | 309.34K |
Income before tax | -55.06M | -43.88M | -41.26M | 5.45M | -18.03M |
Income tax expense | 15.49M | -832.75K | -703.18K | 1.18K | 2.45K |
Net income | -70.56M | -43.05M | -40.56M | 5.45M | -18.03M |
Earnings per share | |||||
Basic EPS | -1.61 | -1.02 | -0.97 | 0.14 | -0.5 |
Diluted EPS | -1.61 | -1.02 | -0.97 | 0.13 | -0.5 |